|
Predicted coverage based on exact match to 4CMenB componentsa
|
---|
CC
|
ST
|
Serogroup
|
# of isolates
|
fHbpb
|
NHBA
|
NadA-2/3c
|
PorA
|
---|
ST-41/44
|
ST-41
|
B
|
1
|
Possibly, 4
|
Yes
|
No
|
Yes
|
|
ST-154
|
B
|
1
|
Possibly, 4
|
Yes
|
No
|
Yes
|
|
ST-41
|
B
|
1
|
Possibly, 4
|
Yes
|
No
|
No
|
|
ST-1194
|
B
|
1
|
Possibly, 4
|
Yes
|
No
|
No
|
|
ST-8052
|
B
|
1
|
Possibly, 14
|
Yes
|
No
|
No
|
|
ST-10619
|
B
|
1
|
Possibly, 100
|
Yes
|
No
|
No
|
ST-32 CC
|
ST-32
|
B
|
2
|
Yes, 1
|
Unknown
|
No
|
No
|
ST-174 CC
|
ST-1466
|
Y
|
1
|
No
|
Unknown
|
8
|
No
|
Additional coverage based on strains predicted to express NadA-1,2/3 and/or Novartis variant 1 fHbp peptides
|
ST-269 CC
|
ST-269
|
B
|
143
|
Possibly, 15
|
Unknown
|
No
|
No
|
|
ST-1986
|
B
|
4
|
Possibly, 15
|
Unknown
|
No
|
No
|
|
ST-5494
|
B
|
3
|
Possibly, 15
|
Unknown
|
No
|
No
|
|
ST-8767
|
B
|
1
|
Possibly, 15
|
Unknown
|
No
|
No
|
|
ST-8880
|
B
|
1
|
Possibly, 15
|
Unknown
|
No
|
No
|
|
ST-2738
|
B
|
1
|
Possibly, 249
|
Unknown
|
No
|
No
|
ST-32 CC
|
ST-33
|
B
|
1
|
Possibly, 144
|
Unknown
|
85
|
No
|
|
ST-2726
|
B
|
2
|
No
|
Unknown
|
1
|
No
|
ST-35 CC
|
ST-278
|
B
|
1
|
Possibly, 4
|
Unknown
|
No
|
No
|
ST-1157 CC
|
ST-1157
|
B
|
2
|
Possibly, 13
|
Unknown
|
No
|
No
|
ST-60 CC
|
ST-10587
|
B
|
1
|
Possibly, 13
|
Unknown
|
No
|
No
|
ST-254 CC
|
ST-10332
|
B
|
1
|
Possibly, 13
|
Unknown
|
No
|
No
|
Not assignedd
|
ST-336
|
B
|
1
|
No
|
Unknown
|
3
|
No
|
|
ST-7655
|
B
|
1
|
Possibly, 13
|
Unknown
|
No
|
No
|
|
ST-7704
|
B
|
1
|
Possibly, 110
|
Unknown
|
No
|
No
|
|
ST-9248
|
B
|
1
|
Possibly, 12
|
Unknown
|
No
|
No
|
ST-11 CC
|
ST-11
|
C
|
2
|
No
|
Unknown
|
3
|
No
|
|
ST-11
|
C
|
1
|
No
|
Unknown
|
2
|
No
|
|
ST-11
|
C
|
1
|
Possibly, 12
|
Unknown
|
No
|
No
|
|
ST-11
|
C
|
1
|
Possibly, 129
|
Unknown
|
No
|
No
|
|
ST-11
|
C
|
1
|
Possibly, 218
|
Unknown
|
No
|
No
|
ST-167 CC
|
ST-6171
|
Y
|
1
|
Possibly, 278
|
Unknown
|
No
|
No
|
-
a4CMenB vaccine components include: factor H binding protein (fHbp) peptide 1; Neisseria Heparin Binding Antigen (NHBA) peptide 2; Neisseria adhesion A (NadA)-2/3 peptide 8; and outer membrane protein porin A (PorA) P1.4
-
bNovartis variant 1 peptides were indicated by their peptide number possibly covered by the vaccine; whereas variants 2/3 peptides were labelled as No to indicate no match or not covered by the 4CMenB vaccine
-
cNadA variant 1-3 peptides were indicated by their peptide number; whereas No was used to indicate absence of the nadA gene
-
dNot assigned to any known clonal complex according to the current Neisseria MLST website (http://pubmlst.org/neisseria/)